Top Health Tech Companies in Minneapolis, MN (112)
Who We Are Chewy is where pet parents find everything they need for life with pets, from food to fun to pharmacy. We make pet care easier, more informed, and more joyful through fast, reliable delivery and award-winning 24/7 Customer Care, including access to pet health support when it’s needed. Founded in 2011, Chewy combines the convenience of online shopping with...
Chewy's Top Stability & Growth Strengths
Customer Loyalty & Retention: Autoship accounts for the vast majority of sales (over four-fifths) and is growing faster than total revenue, indicating a sticky, recurring base and higher retention. Evidence includes Autoship representing ~83% of FY2025 net sales and ~84.6% in Q2 FY2026 with high single‑digit to double‑digit growth.
Profitability: Operating metrics show expanding earnings power, with adjusted EBITDA up materially and margins improving alongside strong free cash flow. Observations include FY2025 adjusted EBITDA growth of ~26% with margin expansion and additional year‑over‑year gains reported in 1H FY2026.
Strong Market Position & Advantage: Chewy is characterized as the largest U.S. pet e‑tailer and a leading online pet‑supplies platform by GMV and digital presence, underpinning durable scale advantages. Multiple summaries highlight leadership in online pet retail, substantial Autoship penetration, and strong digital search share versus specialty peers.
Optum, part of the UnitedHealth Group family of businesses, is a global organization that delivers care, aided by technology to help millions of people live healthier lives. The work you do with our team will directly improve health outcomes by connecting people with the care, pharmacy benefits, data and resources they need to feel their best. Here, you will find...
.jpg)
Optum's Top Stability & Growth Strengths
Strong Revenue Growth: Optum’s consolidated revenue expanded from $253.0B in 2024 to $270.6B in 2025, indicating continued top-line growth. Multi‑year reporting also highlights ongoing increases at the consolidated level even as segment performance diverges.
Diversified Revenue Streams: Performance is spread across three businesses, with Optum Rx delivering substantial gains, Optum Insight growing modestly, and Optum Health contracting. This mix shows pharmacy and technology services helping sustain overall scale despite softness in care delivery.
Cost & Operational Efficiency: Operating performance improved in 2026 as Optum’s operating income rose year over year to about $4B in Q2 alongside reported gains in technology and clinical operations. UnitedHealth also raised its 2026 adjusted EPS outlook, signaling confidence in execution.
Integer Holdings Corporation (NYSE:ITGR) is a leader in advanced medical device outsourcing (MDO) and serves its customers by providing comprehensive end-to-end solutions with its unparalleled expertise in innovation and manufacturing. Integer's vision is to enhance the lives of patients worldwide by being its customer's partner of choice for innovative medical technologies and services. Additionally, through Electrochem, an Integer company, it...
Integer Holdings Corporation's Top Stability & Growth Strengths
Strong Market Position & Advantage: Feedback suggests Integer is broadly regarded as a top‑tier CDMO, with particular leadership across cardio/vascular and CRM/neuromodulation and consistent recognition in industry roundups. Analyst commentary also frames the company as a scaled consolidator capable of above‑market organic growth in a consolidating outsourcing market.
Strong Revenue Growth: Feedback suggests 2025 was a solid growth year with sales up 8% to about $1.854B and Q4 2025 sales up 5%, alongside double‑digit expansion in adjusted operating income and EBITDA. Multi‑year context shows sustained growth through 2024–2025 before the current pause.
Future-Ready Strategy: Feedback suggests the company sharpened focus by divesting its non‑medical Electrochem business and investing in high‑growth capabilities such as coatings (Precision Coating, VSi Parylene, Biocoat assets). Management also targets a return to 200 bps above‑market organic growth in 2027 as current headwinds abate.
At Sonder, we help organisations improve the wellbeing of their people and empower them to be at their best. We do this by providing leaders with a comprehensive care platform that delivers support through the right care, at the right time. Allowing people take control of their wellbeing in a way that suits them - on their terms, on their...
Siemens Healthineers is a leading medtech company with over 125 years of experience. Our portfolio, spanning from in-vitro and in-vivo diagnostics to image-guided therapy and innovative cancer care, is crucial for clinical decision-making and treatment pathways. With our strengths in patient twinning, precision therapy, as well as digital, data, and artificial intelligence (AI), we are well positioned to take on...
Siemens Healthineers's Top Stability & Growth Strengths
Strong Revenue Growth: Comparable revenue increased in FY2025 and the company reports a positive start to FY2026 on a comparable basis while reaffirming its full-year comparable growth guidance.
Profitability: Adjusted EBIT margin rose in FY2025, and free cash flow improved alongside a higher proposed dividend, indicating strengthened operating performance and shareholder returns.
Strong Market Position & Advantage: The company is positioned as a leader in medical technology, with noted dominance in diagnostic imaging and continued momentum in Imaging and Precision Therapy helping sustain growth despite pressures elsewhere.
STERIS is a leading provider of infection prevention and other procedural products and services, focused primarily on healthcare, pharmaceutical and medical device Customers. MISSION WE HELP OUR CUSTOMERS CREATE A HEALTHIER AND SAFER WORLD by providing innovative healthcare and life science products and services around the globe. VISION We strive to be a GREAT COMPANY. We provide world-class products and services for our Customers,...
STERIS's Top Stability & Growth Strengths
Strong Revenue Growth: Revenue from continuing operations grew 9% in FY2026 with 7% constant-currency organic growth, extending momentum from FY2025. Guidance for FY2027 calls for 7–8% reported revenue growth and 9–11% adjusted EPS growth.
Healthy Cash Flow: Operating cash flow reached about $1.34B and free cash flow was $983M in FY2026, both above the prior year. A new $1B share repurchase authorization underscores capacity to return capital.
Strong Market Position & Advantage: STERIS is widely viewed as a leader across infection prevention and sterilization, often top‑two with Getinge in equipment and co‑leading outsourced sterilization with Sotera. Competitor filings explicitly naming STERIS AST as a primary rival validate its top‑tier standing.
Hint, the San Francisco-based company founded by entrepreneur Kara Goldin in 2005, is a healthy lifestyle brand known for its delicious unsweetened flavored water.
A trusted resource for hearing solutions for over 75 years, Miracle-Ear uses state-of-the-art technology to remove the barriers of hearing loss. The Minneapolis, MN-based company specializes in custom hearing solutions that feature discreet, comfortable products designed to meet each individual's hearing loss needs. Free hearing tests are available at all of the company's 1,500 franchised locations nationwide. Franchise opportunities are...
Abbott is a global healthcare leader that helps people live more fully at all stages of life. Our portfolio of life-changing technologies spans the spectrum of healthcare, with leading businesses and products in diagnostics, medical devices, nutritionals and branded generic medicines. Our 109,000 colleagues serve people in more than 160 countries.
Abbott's Top Stability & Growth Strengths
Strong Revenue Growth: Q2 2026 sales increased 13% reported (4.8% comparable), and management reaffirmed 6.5%–7.5% comparable sales growth while lifting full‑year EPS guidance. Multi‑segment contribution from Medical Devices and Diagnostics underpins a mid‑single‑digit organic growth trajectory.
Strong Market Position & Advantage: Leadership across CGM (FreeStyle Libre), structural heart TEER (MitraClip/TriClip), and core lab diagnostics supports top‑tier scale in medtech. The March 23, 2026 addition of Exact Sciences’ oncology screening and diagnostics further strengthens competitive positioning.
Diversified Revenue Streams: A broad mix across Devices, Diagnostics, Nutrition, and Established Pharmaceuticals reduces single‑category risk, with recurring models like Alinity’s instrument‑reagent base driving stickiness. Expansion into oncology diagnostics post‑acquisition adds another distinct growth engine.
Patterson strengthens the oral and animal health markets in North America and the United Kingdom. From small, private practices to large group networks and production operations, we guide our customers with bold solutions and a personal touch. We are much more than a distributor – we are an indispensable partner. Patterson Dental has strengthened the dental industry since our company’s founding...
Patterson Companies's Top Stability & Growth Strengths
Strong Market Position & Advantage: The company is described as a top‑tier distributor in North American dental and a leading player in animal health, supported by long operating history and logistical moats. Its role alongside Henry Schein in an oligopolistic dental channel, and leadership in the U.K. via NVS, indicate durable competitive positioning.
Diversified Revenue Streams: Operations span two large divisions—Dental and Animal Health—complemented by value‑added services and software. This mix has provided some balance, with steadier Animal Health trends partially offsetting softer Dental performance.
Investor Backing & Capital Strength: The acquisition by Patient Square Capital supplies committed sponsorship and resources for the next phase under private ownership. Leadership changes and continued bolt‑on deals signal a capital‑supported agenda for operational improvements and selective expansion.
Fabric Health is a pioneering care access platform dedicated to solving one of healthcare's most pressing challenges: operational capacity. We equip health systems, health plans, employers, and brokers with consumer-grade solutions designed to make healthcare faster, smarter, and more accessible at the exact moment of need. Our core mission is to empower boundless care through seamless, intuitive experiences that benefit...
Fabric Health's Top Stability & Growth Strengths
Strong Market Position & Advantage: Within care enablement and digital front door, the company is described as a category leader with unusually comprehensive coverage across triage, navigation, scheduling, virtual visits, and a 50‑state clinical network. Third‑party lists (CB Insights, DHNY, AVIA) and scale signals (relationships with 75+ health systems and 30,000 employers) suggest rising standing among peers.
Strong Revenue Growth: Company materials cite triple‑digit annual sales growth alongside ongoing product launches and new deployments through 2025–2026. Reported reach of roughly 100M covered lives and expanding enterprise relationships indicate accelerating topline momentum.
Investor Backing & Capital Strength: A $60M Series A in 2024 aligns with an aggressive build‑and‑buy strategy that includes multiple acquisitions over a short period. This funding posture supports continued platform development and distribution expansion.
Cassia is a non-profit organization that provides senior housing, health care, and community-based services to older generations and others in need—and helps residents live the lives that most inspire them. The principles that guide our work: ·To value older generations’ talents and experience ·To provide the care residents need, when and where they need it ·To connect residents to the people and things that...
Prenuvo is a fast growing health tech company specializing in whole body diagnostic imaging. We are a global leader in whole body MRI screening with a track record of early detection of cancer and other major health diseases. In an era of reactive and fragmented health screening, Prenuvo is rooted in early detection through cutting-edge imaging technology. Our technology brings together...
Tactile Medical is one of the fastest growing companies in medical devices. As a leader in treatment options for lymphedema and venous ulcer therapies, Tactile Medical develops advanced home therapy devices to improve health and quality of life for patients with chronic swelling . Headquartered in Minneapolis, Minnesota, we advocate for patient access and serve tens of thousands of patients...
HealthPartners, an integrated health care organization providing health care services and health plan financing and administration, was founded in 1957 as a cooperative. It's the largest consumer governed nonprofit health care organization in the nation – serving more than 1.8 million medical and dental health plan members nationwide. Our care system includes a multi-specialty group practice of more than 1,800...
M Health Fairview is the newly expanded academic health system that represents a collaboration among the University of Minnesota, University of Minnesota Physicians, and Fairview Health Services. The partnership combines the university’s deep history of clinical innovation and training with Fairview’s extensive roots in community medicine. Together, we’re expanding access to world-class, patient-centered care through our 10 hospitals, 60 primary...
Teal Health is on a mission to empower women when it comes to their health – starting with at-home cervical cancer screenings. We believe that it’s time for women’s health to be designed for women, their preferences, and their experiences. With this in mind, Teal Health is creating the first FDA-approved at-home cervical cancer screening making it simple for a...
At HHAeXchange, we believe that healthcare should be simple, effective, and transparent. Since 2008, HHAeXchange has been at the forefront of delivering better homecare by helping payers and providers achieve operational efficiency, increase compliance, and improve patient outcomes. Today, HHAeXchange is the premiere homecare management software for the Medicaid LTSS population. Our acquisition of Annkissam, a leading provider of enterprise software...
Planned Parenthood Great Rivers is a patient-focused health care organization that provides, protects, and supports sexual and reproductive health services, access, and rights. It serves as a leading provider, educator, and protector of reproductive health care in the St. Louis region, Missouri Ozarks, and beyond, offering high-quality, convenient health care for all genders with or without insurance.
Spectrum Plastics Group is a global leader in the design, development, and manufacturing of specialty medical components and devices, providing solutions from development through scaled manufacturing for medical and other demanding markets.
Spectrum Plastics Group's Top Stability & Growth Strengths
Strong Market Position & Advantage: The company is broadly regarded as a leader in polymer-based medical components and catheter technologies, serving many major OEMs and frequently making tier-one shortlists. DuPont’s 2023 acquisition explicitly described it as a recognized leader, reinforcing perceived competitive advantage.
Market Expansion: Recent moves include facility expansions and capability additions in Costa Rica, Minneapolis, Pleasant Prairie, Sandy, and Wall, increasing cleanroom space, extrusion lines, and catheter assembly capacity. These upgrades aim to raise throughput, shorten lead times, and strengthen supply resilience across key medtech hubs.
Investor Backing & Capital Strength: DuPont’s $1.75B acquisition and subsequent addition of Donatelle integrate Spectrum into a larger healthcare platform with materials synergies and balance-sheet support. Ongoing site investments under DuPont indicate continued capital commitment to scale and capability growth.
